Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.77%
#4 aPriori aPriori +120.78%
#5 Bedrock Bedrock +76.11%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.13%
#9 COTI COTI +25.33%
#10 Nillion Nillion +24.72%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Clasificación en acciones #42678
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Precio por acción
$0.00001
Última sincronización: 2026-07-30
Capitalización bursátil
$426.00
Cambio (1 día)
0.00%
Cambio (1 año)
-90.00%
País
US
Comercio Kaleido Biosciences, Inc. (KLDO)

Categoría

Healthcare
Historial del precio de la acción de Kaleido Biosciences, Inc. (KLDO)
Precio más alto de cierre: $0.00 el 2026-07-01

Precio más bajo de cierre: $14.23 el 2019-02-01
Historial del precio de la acción de Kaleido Biosciences, Inc. desde 2019 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR